Kisspeptin for hormones and libido: what TikTok gets wrong

What's this video probably claiming?

Based on the caption and hashtags, this creator is almost certainly positioning kisspeptin as a supplement or peptide therapy that women (and possibly men) can use to "balance hormones," boost libido, regulate the HPG axis, and support fertility. The aesthetic framing, pink emojis, and hashtags like #hormonalimbalance and #fertility suggest the target audience is women struggling with cycle irregularities, low sex drive, or subfertility. The claim pattern follows a well-worn TikTok formula: list five vague benefits, attach a peptide name, and let the algorithm do the rest. What's likely missing from this video is any distinction between kisspeptin as a research peptide used in clinical trials under controlled IV or subcutaneous dosing protocols versus whatever oral supplement or compounded injection someone might actually purchase. That gap between the clinical literature and the product being implicitly promoted is where most of the misinformation lives.

What does the science actually show?

Kisspeptin is a neuropeptide encoded by the KISS1 gene that acts as a key upstream regulator of gonadotropin-releasing hormone (GnRH) neurons. That part is real and well-established. Dhillo et al. (2005, Journal of Clinical Endocrinology and Metabolism) demonstrated that intravenous kisspeptin-54 administration at 0.24 nmol/kg dose-dependently increased LH secretion in healthy men. Later work by Jayasena et al. (2014, Clinical Endocrinology) showed intranasal kisspeptin could stimulate LH pulses in women with hypothalamic amenorrhea. In reproductive medicine, kisspeptin has been studied as a trigger for oocyte maturation during IVF, with Abbara et al. (2020, Journal of Clinical Investigation) reporting successful oocyte retrieval using kisspeptin-54 at 9.6 nmol/kg IV as an alternative to hCG. These are real, promising signals, but every single one of these trials used pharmaceutical-grade peptide, precise IV or subcutaneous dosing, and clinical monitoring. None of this translates cleanly to self-administered peptide therapy.

Where does the social media noise diverge from clinical reality?

The divergence is significant. First, oral kisspeptin has essentially no bioavailability data supporting systemic hormonal effects. Peptides are digested. Second, the "libido" claim is extrapolated from a study by Comninos et al. (2017, JCI Insight) that showed kisspeptin infusion increased activity in brain regions associated with sexual and emotional processing in men, but this was a single-dose IV infusion study, not a supplement trial. Mapping that finding onto a TikTok claim about libido supplements is a stretch. Third, the fertility claim conflates the IVF trigger research (extremely controlled clinical setting) with general fertility support, which is not what the literature shows. Fourth, "hormonal balance" is not a clinical endpoint in any kisspeptin trial. It's marketing language. The hashtag #hormonalimbalance particularly concerns me because it implies kisspeptin corrects a diagnosed condition, and there is no regulatory approval or clinical guideline supporting that use in any country.

What should you actually know?

Kisspeptin is genuinely interesting science. It is not a wellness supplement. If you have hypothalamic amenorrhea, PCOS-related anovulation, or are undergoing IVF, kisspeptin is being studied in legitimate clinical trials and the early results are worth watching. The dose matters enormously because the HPG axis responds differently to pulsatile versus continuous kisspeptin exposure, and getting that wrong can suppress rather than stimulate LH. Compounded kisspeptin peptides sold outside of clinical trial protocols have no verified purity standards, no pharmacokinetic data in the target populations, and no post-market surveillance. If a creator is implying you should buy or inject kisspeptin based on a 60-second TikTok, that is not a health recommendation rooted in the available evidence. Talk to a reproductive endocrinologist or a licensed telehealth provider who can actually evaluate your hormone panel before anyone touches your HPG axis.